FDA Panel's "Misinformation" on Antidepressant Use in Pregnancy

A recent expert panel organized by the U.S. Food and Drug Administration cast doubt on the safety of SSRIs in pregnancy -- sparking backlash from medical institutions and doctors. Lauren Osborne, M.D., vice chair of Clinical Research at the Department of OBGYN at Weill Cornell Medicine and chair of The National Curriculum in Reproductive Psychiatry (NCRP), explains what the science says about antidepressant use during pregnancy.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.